Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,535
Closed -$2.08M 408
2023
Q2
$2.08M Sell
9,535
-319
-3% -$71.1K 0.16% 118
2023
Q1
$2.16M Sell
9,854
-7,794
-44% -$1.69M 0.17% 114
2022
Q4
$3.67M Sell
17,648
-1,620
-8% -$356K 0.29% 73
2022
Q3
$4.21M Sell
19,268
-8,060
-29% -$1.83M 0.35% 63
2022
Q2
$5.73M Sell
27,328
-242
-0.9% -$51.5K 0.43% 54
2022
Q1
$6.69M Sell
27,570
-2,101
-7% -$508K 0.43% 54
2021
Q4
$7.73M Sell
29,671
-1,025
-3% -$266K 0.48% 53
2021
Q3
$8.09M Buy
30,696
+94
+0.3% +$25.7K 0.52% 44
2021
Q2
$7.54M Sell
30,602
-4,534
-13% -$953K 0.48% 49
2021
Q1
$6.82M Sell
35,136
-5,155
-13% -$1.03M 0.51% 54
2020
Q4
$8.56M Sell
40,291
-493
-1% -$98.3K 0.64% 45
2020
Q3
$6.99M Sell
40,784
-1,474
-3% -$272K 0.6% 49
2020
Q2
$8.11M Sell
42,258
-278
-0.7% -$45.5K 0.75% 35
2020
Q1
$6.26M Buy
42,536
+4,234
+11% +$674K 0.69% 41
2019
Q4
$5.94M Sell
38,302
-609
-2% -$87.8K 0.58% 50
2019
Q3
$5.26M Sell
38,911
-199
-0.5% -$26.1K 0.55% 55
2019
Q2
$4.77M Buy
39,110
+910
+2% +$101K 0.51% 58
2019
Q1
$3.97M Buy
+38,200
New +$3.94M 0.46% 69

Other funds holding RMD

Equitable Trust's RMD Position: Q3 2023 in Review

Equitable Trust sold out of ResMed (RMD) in Q3 2023, closing a stake of 9,535 shares — an estimated $2.08M sold.

Equitable Trust first reported a position in RMD in Q1 2019 and held it in 18 quarters. The position peaked at $8.56M in Q4 2020. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Equitable Trust reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Equitable Trust sold 9,535 ResMed shares in Q3 2023, an estimated $2.08M.
  • Equitable Trust first reported a position in ResMed in Q1 2019 and held it in 18 quarters.
  • Equitable Trust's ResMed position peaked at $8.56M in Q4 2020.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Equitable Trust's 13F filing for Q3 2023, filed 6 Nov 2023.